Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Oncogene ; 31(27): 3223-34, 2012 Jul 05.
Artículo en Inglés | MEDLINE | ID: mdl-22056872

RESUMEN

The role of estrogen receptor-α (ER) in breast cancer development, and as a primary clinical marker for breast cancer prognosis, has been well documented. In this study, we identified the oncogenic protein, TWIST1 (Twist), which is overexpressed in high-grade breast cancers, as a potential negative regulator of ER expression. Functional characterization of ER regulation by Twist was performed using Twist low (MCF-7, T-47D) and Twist high (Hs 578T, MDA-MB-231, MCF-7/Twist) expressing cell lines. All Twist high expressing cell lines exhibited low ER transcript and protein levels. By chromatin immunoprecipitation and promoter assays, we demonstrated that Twist could directly bind to E-boxes in the ER promoter and significantly downregulate ER promoter activity in vitro. Functionally, Twist overexpression caused estrogen-independent proliferation of breast cells, and promoted hormone resistance to the selective estrogen receptor modulator tamoxifen and selective estrogen receptor down-regulator fulvestrant. Importantly, this effect was reversible on downregulating Twist. In addition, orthotopic tumors generated in mice using MCF-7/Twist cells were resistant to tamoxifen. These tumors had high vascular volume and permeability surface area, as determined by magnetic resonance imaging (MRI). Mechanistically, Twist recruited DNA methyltransferase 3B (DNMT3B) to the ER promoter, leading to a significantly higher degree of ER promoter methylation compared with parental cells. Furthermore, we demonstrated by co-immunoprecipitation that Twist interacted with histone deacetylase 1 (HDAC1) at the ER promoter, causing histone deacetylation and chromatin condensation, further reducing ER transcript levels. Functional re-expression of ER was achieved using the demethylating agent, 5-azacytidine, and the HDAC inhibitor, valproic acid. Finally, an inverse relationship was observed between Twist and ER expression in human breast tumors. In summary, the regulation of ER by Twist could be an underlying mechanism for the loss of ER activity observed in breast tumors, and may contribute to the generation of hormone-resistant, ER-negative breast cancer.


Asunto(s)
Antineoplásicos/farmacología , Neoplasias de la Mama/tratamiento farmacológico , Neoplasias de la Mama/metabolismo , Regulación hacia Abajo/efectos de los fármacos , Resistencia a Antineoplásicos/genética , Receptor alfa de Estrógeno/genética , Proteínas Nucleares/metabolismo , Proteína 1 Relacionada con Twist/metabolismo , Acetilación/efectos de los fármacos , Animales , Azacitidina/farmacología , Neoplasias de la Mama/irrigación sanguínea , Neoplasias de la Mama/genética , Neoplasias de la Mama/patología , Permeabilidad Capilar/efectos de los fármacos , Línea Celular Tumoral , Cromatina/efectos de los fármacos , Cromatina/genética , Cromatina/metabolismo , ADN (Citosina-5-)-Metiltransferasas/metabolismo , Metilación de ADN/efectos de los fármacos , Regulación hacia Abajo/genética , Elementos E-Box/efectos de los fármacos , Elementos E-Box/genética , Estrógenos/metabolismo , Femenino , Histona Desacetilasa 1/antagonistas & inhibidores , Histonas/metabolismo , Humanos , Ratones , Proteínas Nucleares/deficiencia , Proteínas Nucleares/genética , Regiones Promotoras Genéticas/efectos de los fármacos , Regiones Promotoras Genéticas/genética , Transporte de Proteínas/efectos de los fármacos , ARN Interferente Pequeño/genética , Tamoxifeno/farmacología , Proteína 1 Relacionada con Twist/deficiencia , Proteína 1 Relacionada con Twist/genética , Ácido Valproico/farmacología , ADN Metiltransferasa 3B
3.
Arch Biochem Biophys ; 382(2): 232-7, 2000 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-11068874

RESUMEN

Peroxidases catalyze many reactions, the most common being the utilization of H2O2 to oxidize numerous substrates (peroxidative mode). Peroxidases have also been proposed to produce H2O2 via utilization of NAD(P)H, thus providing oxidant either for the first step of lignification or for the "oxidative burst" associated with plant-pathogen interactions. The current study with horseradish peroxidase characterizes a third type of peroxidase activity that mimics the action of catalase; molecular oxygen is produced at the expense of H2O2 in the absence of other reactants. The oxygen production and H2O2-scavenging activities had temperature coefficients, Q10, of nearly 3 and 2, which is consistent with enzymatic reactions. Both activities were inhibited by autoclaving the enzyme and both activities had fairly broad pH optima in the neutral-to-alkaline region. The apparent Km values for the oxygen production and H2O2-scavenging reactions were near 1.0 mM H2O2. Irreversible inactivation of horseradish peroxidase by exposure to high concentrations of H2O2 coincided with the formation of an absorbance peak at 670 nm. Addition of superoxide dismutase (SOD) to reaction mixtures accelerated the reaction, suggesting that superoxide intermediates were involved. It appears that horseradish peroxidase is capable of using H2O2 both as an oxidant and as a reductant. A model is proposed and the relevance of the mechanism in plant-bacterial systems is discussed.


Asunto(s)
Peroxidasa de Rábano Silvestre/metabolismo , Peróxido de Hidrógeno/metabolismo , Oxígeno/metabolismo , Catalasa/metabolismo , Catálisis , Depuradores de Radicales Libres/metabolismo , Técnicas In Vitro , Cinética , Modelos Biológicos , Plantas/metabolismo , Superóxido Dismutasa/metabolismo
4.
Biochem Biophys Res Commun ; 252(2): 461-4, 1998 Nov 18.
Artículo en Inglés | MEDLINE | ID: mdl-9826552

RESUMEN

Diphenyleneiodonium (DPI) has been used frequently as a specific inhibitor of NADH oxidase activity in studies of plant/pathogen interactions. The present study reports the effect of DPI on the pseudo-oxidative activity of horseradish peroxidase. DPI, like other phenolics, is able to catalytically stimulate NADH oxidation in the presence of exogenous H2O2. The stimulated NADH oxidation has an acidic pH optimum and has an apparent Km of 111 microM NADH. The NADH oxidation rate is linearly proportional to [DPI] and the amount of NADH oxidized is proportional to [H2O2]. Once exogenous H2O2 is depleted, the NADH oxidation is abruptly halted until additional H2O2 is supplied. In some respects DPI appears to mimic the effects of certain anti-oxidants that use HRP to scavenge H2O2 and NAD(P)H as a reductant.


Asunto(s)
Complejos Multienzimáticos/antagonistas & inhibidores , NADH NADPH Oxidorreductasas/antagonistas & inhibidores , NADPH Oxidasas/antagonistas & inhibidores , Compuestos Onio/farmacología , Oxígeno/metabolismo , Plantas/metabolismo , Plantas/microbiología , Bacterias/metabolismo , Bacterias/patogenicidad , Inhibidores Enzimáticos/farmacología , Peroxidasa de Rábano Silvestre/antagonistas & inhibidores , Peróxido de Hidrógeno/metabolismo , Concentración de Iones de Hidrógeno , Cinética , Oxidación-Reducción , Especies Reactivas de Oxígeno/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA